Rebecca Smith, MD
Dermatology · Fort Mill, SCNPI 1366412033
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,731,795 of the $2,281,135 with a category attached, or 75.9%. It is spread thinly across 42 manufacturers, the largest accounting for just 21.6%. Among dermatology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,993 payments — averaging $762.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$492K
- Sanofi$259K
- Regeneron Healthcare Solutions, Inc.$244K
- Arcutis Biotherapeutics, Inc.$219K
- Lilly USA, LLC$218K
- Pfizer$184K
- plus $664K from 36 others
Across 1 payment — averaging $522.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$522
What the payments were for
- Consulting fees$268,91712%
- Speaking & faculty fees$1,731,79576%
- Travel & lodging$214,8759%
- Food & beverage$64,8553%
- Education$6920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,281,135 in reported general payments places this provider in the 95th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 74 | $3,961 |
| Doxycycline Hyclate | 152 | $3,761 |
| Metronidazole | 40 | $2,383 |
| Fluorouracil | 23 | $1,254 |
| Triamcinolone Acetonide | 119 | $1,086 |
| Betamethasone Dipropionate | 17 | $902 |
| CiclopiroxCiclopirox Olamine | 48 | $718 |
| Ketoconazole | 52 | $638 |
| ValacyclovirValacyclovir Hcl | 19 | $581 |
| Mupirocin | 72 | $547 |
| Cephalexin | 20 | $142 |
| Nystatin | 13 | $140 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Mill
- Julie IanniniFort Mill$15K
- Anne SextonFort Mill$14K
- Marshall ShulerGreenville$2.6M
- Todd SchlesingerCharleston$1.9M
- Amylynne FrankelSpartanburg$987K
- Marguerite GermainMt Pleasant$200K
- George KeoughPawleys Island$150K
- Christopher MartinAbbeville$129K
- Lee CarsonGreenville$127K
- Mark SiegelCharleston$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.